MB-EMAU

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameMB-EMAU
Drug Alias NameMBEMAU
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA-directed DNA polymerase inhibitors
TargetsDNA-directed DNA polymerase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlsynthesis IncUniversity Of Massachusetts Medical School
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlsynthesis IncUniversity Of Massachusetts Medical School
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A